Published on 8 Sep 2023 on Zacks via Yahoo Finance
Here's Why You Should Retain Bruker (BRKR) Stock for Now
Bruker Corporation BRKR is well-poised for growth in the coming quarters due to the strong performance of the Bruker CALID and NANO groups. Bruker’s announcement to acquire PhenomeX is a significant step in functional single-cell biology research solutions.
However, the company’s operations are exposed to intense competition from its peers in the industry. Mounting expenses weighing on the margin are also concerning for Bruker.
In the past year, this Zacks Rank #3 (Hold) stock has increased 10.1% against the 18.9% fall of the industry and an 11.6% rise of the S&P 500 composite.